Vertex Pharmaceuticals Inc (VRTX) stock
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3028% above fair value
$547.03−0.86 (-0.16%)
Close on Nov 11, 2026Market cap $138.65BP/E 31.8Yield –
Vertex Pharmaceuticals statistics
102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 7.40
- 2.39
- P/OCF Ratio
- 32.30
- 13.11
Enterprise valuationIndustry
- EV / Sales
- 10.39
- 2.65
- EV / EBIT
- 27.38
- 19.03
- EV / FCF
- 34.46
- 22.15
Share statisticsIndustry
- Shares Change (YoY)
- -1.10%
- 10.9%
- Shares Change (QoQ)
- -0.32%
- 0.51%
- Float
- 253M
- 49M
- Shares Held by Insiders
- 0.22%
- 11.6%
- Shares Held by Institutions
- 95.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 12.9%
- -0.76%
- Short % of Float
- 1.90%
- 9.06%
- Short % of Shares Outstanding
- 1.90%
- 6.38%
- Days to Cover
- 3.38
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $568.67
- –
- 52-Week Low
- $412.27
- –
- 20-Day Moving Average
- $532.21
- –
- 50-Day Moving Average
- $523.04
- –
- 200-Day Moving Average
- $482.70
- –
- Average True Range (14)
- $16.58
- –
- Price Change (1 Week)
- -0.37%
- -0.50%
- Price Change (1 Month)
- 12.7%
- -0.33%
- Price Change (3 Months)
- 5.92%
- -17.2%
- Price Change (6 Months)
- 20.7%
- -20.1%
- Price Change (YTD)
- 20.7%
- -20.1%
- Price Change (1 Year)
- 29.9%
- -19.3%
- Price Change (3 Years)
- 46.4%
- -23.4%
- Price Change (5 Years)
- 192.1%
- -76.4%
- Price Change (10 Years)
- 494.6%
- -62.4%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.82
- 0.73
- Relative Strength Index (14)
- 57.3
- 47.6
- Volatility (1 Year)
- 29.6%
- 80.2%
- Beta (5 Years)
- 0.53
- 1.07
MarginsIndustry
- Pretax Margin
- 41.9%
- -12.1%
- EBITDA Margin
- 39.7%
- -25.0%
- FCF Margin
- 30.2%
- -9.55%
Returns on capitalIndustry
- Return on Equity (ROE)
- 23.5%
- -51.3%
- Return on Assets (ROA)
- 17.1%
- -40.3%
- Return on Invested Capital (ROIC)
- 34.4%
- -34.0%
- Return on Capital Employed (ROCE)
- 20.3%
- -37.7%
Financial positionIndustry
- Current Ratio
- 3.19
- 3.30
- Quick Ratio
- 2.54
- 2.37
GrowthIndustry
- Revenue Growth (YoY)
- 10.2%
- 7.01%
- Net Income Growth (YoY)
- 21.1%
- -24.7%
- EPS Growth (YoY)
- 22.4%
- -12.8%
- FCF Growth (YoY)
- 8.47%
- 6.85%
- Revenue Growth (3Y CAGR)
- 10.4%
- 2.25%
- Revenue Growth (5Y CAGR)
- 14.1%
- 6.41%
- EPS Growth (3Y CAGR)
- 6.12%
- -0.17%
- EPS Growth (5Y CAGR)
- 8.29%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.49
- 0.40
- Inventory Turnover
- 1.08
- 2.68
- Revenue Per Employee
- $20.98K
- $426.63K
- Profits Per Employee
- $7.34K
- -$680.86K
- Employee Count
- 600,000
- 75
- WACC
- 7.52%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $5.27B
- -$13.50M
Balance sheetIndustry
- Net Cash (Debt)
- $7.85B
- $16.31M
- Net Cash Per Share
- $30.98
- $0.70
- Equity (Book Value)
- $20.25B
- $53.12M
- Book Value Per Share
- $79.89
- $1.49
- Tangible Book Value
- $18.75B
- $26.11M
- Working Capital
- $8.61B
- $77.59M
Cash flow (TTM)Industry
- Capital Expenditures
- -$496.80M
- -$939.00K
- FCF Per Share
- $14.98
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 3.18%
- -19.8%
- FCF Yield
- 2.74%
- -8.81%
- Buyback Yield
- 1.45%
- -0.69%
- Shareholder Yield
- 1.45%
- 0.00%
Taxes and interestIndustry
- Income Tax
- $869.30M
- $79.50K
- Effective Tax Rate
- 16.5%
- 20.7%
Scores and fair valueIndustry
- Graham Number
- $175.73
- $19.42
- Graham Upside
- -67.9%
- -45.8%
- Altman Z-Score
- 13.81
- 0.28
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -2.18
- -2.62
- Lynch Fair Value
- $142.34
- –
- Lynch Upside
- -74.0%
- -27.9%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | VRTX | S&P 500 | Difference | VRTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +7.2% | -2.4% | +9.7 pts | ||
| 3 months | +3.3% | -1.2% | +4.4 pts | ||
| Year to date | +20.7% | +12.3% | +8.4 pts | ||
| 1 year | +27.4% | +12.4% | +15.0 pts | ||
| 3 years | +46.4% | +78.8% | −32.4 pts | +13.5% | +21.4% |
| 5 years | +194.3% | +75.2% | +119.1 pts | +24.1% | +11.9% |
| 10 years | +494.6% | +311.1% | +183.5 pts | +19.5% | +15.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M VRTX shares were sold short on Oct 30, 2026, up 12.9% from the previous report, or 1.90% of the shares available to trade. At recent volumes it would take 3.4 days to buy them back. Over the last 20 sessions, 54.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,811,837 | +12.9% | 1,424,337 | 3.4 |
| Oct 15, 2026 | 4,263,331 | -5.3% | 1,257,461 | 3.4 |
| Sep 30, 2026 | 4,503,200 | -4.5% | 1,063,142 | 4.2 |
| Sep 15, 2026 | 4,716,867 | +1.2% | 938,157 | 5.0 |
| Aug 31, 2026 | 4,659,749 | +12.4% | 1,032,621 | 4.5 |
| Aug 14, 2026 | 4,146,973 | +5.2% | 1,343,908 | 3.1 |
| Jul 31, 2026 | 3,942,936 | -20.9% | 1,318,061 | 3.0 |
| Jul 15, 2026 | 4,986,691 | +1.0% | 1,607,817 | 3.1 |
| Jun 30, 2026 | 4,938,472 | +7.0% | 2,454,849 | 2.0 |
| Jun 15, 2026 | 4,616,968 | +2.8% | 1,209,855 | 3.8 |
| May 29, 2026 | 4,491,490 | +0.7% | 1,406,784 | 3.2 |
| May 15, 2026 | 4,461,773 | +6.9% | 1,224,873 | 3.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?